Keyphrases
Asthma
100%
Primary Care
40%
Smokers
40%
Ex-smokers
40%
Hydroxychloroquine
40%
Azithromycin
40%
Hospitalized Patients
40%
Chronic Obstructive Pulmonary Disease
40%
All-cause Mortality
33%
Dyspnea
32%
Remission
27%
Spirometry
25%
Tobacco Exposure
25%
Body Mass Index
25%
Severe Exacerbations
24%
Respiratory Symptoms
22%
Risk Factors
22%
Wheezing
21%
Cor Pulmonale
20%
Canteen
20%
Middle-aged Adults
20%
Christmas
20%
Demographic Risk
20%
Patients with COVID-19
20%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
20%
Coronavirus Disease (COVID)
20%
Blood Eosinophils
20%
Pooled Analysis
20%
Comorbid Risk
20%
Hospital Readmission
20%
Long-term Predictors
20%
Static Lung Volumes
20%
Opportunistic Screening
20%
Retrospective Cohort Study
20%
Hospital Mortality
20%
Lifestyle Risk
20%
Incident Asthma
20%
Randomized Clinical Trial
20%
Intestinal Absorption
20%
Randomized Controlled Trial
20%
Placebo
20%
Severe COPD
20%
Placebo-controlled Trial
20%
Diffusing Capacity
20%
Xylose
20%
COVID-19
20%
Telecare
20%
Structured Summaries
20%
Adult Asthma
20%
Telemonitoring
20%
Medicine and Dentistry
Asthma
87%
Chronic Obstructive Pulmonary Disease
67%
Smoking
42%
Primary Health Care
40%
Symptom
26%
Dyspnea
25%
All Cause Mortality
22%
Telehealth
20%
Health Care
20%
Quality of Life
20%
Lung Diffusion Capacity
20%
Lung Diffusion
20%
Lung Volume
20%
Pooled Analysis
20%
Middle Age
20%
Randomized Clinical Trial
20%
Hydroxychloroquine
20%
Randomized Controlled Trial
20%
COVID-19
20%
Azithromycin
20%
Body Mass Index
17%
Spirometry
13%
Wheeze
12%
Remote Patient Monitoring
11%
Coughing
10%
Bronchodilating Agent
8%
Sputum
7%
Dysentery
6%
4 Aminoquinoline Derivative
6%
Airflow
6%
Sensorineural Hearing Loss
6%
Blood Glucose
6%
Respiratory Medicine
6%
Myasthenia gravis
6%
Interstitial Lung Disease
6%
Intensive Care Unit
6%
Hypersensitivity
6%
Immunomodulation
6%
Gastrointestinal Disease
6%
Retinopathy
6%
Glucose-6-Phosphate Dehydrogenase Deficiency
6%
Internal Medicine
6%
Sulfhemoglobinemia
6%
Menarche
6%
Visual Field
6%
Combination Therapy
6%
Porphyria
6%
Emergency Department
6%
Antibiotics
6%
Antivirus Agent
6%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
87%
Hydroxychloroquine
40%
Azithromycin
40%
Remission
27%
Placebo
27%
Chronic Obstructive Lung Disease
27%
Disease
23%
All Cause Mortality
22%
Cor Pulmonale
20%
Coronavirinae
20%
Randomized Controlled Trial
20%
Xylose
20%
Antibiotics
9%
Antivirus Agent
9%
Symptom
7%
Porphyria
6%
Dysentery
6%
Perception Deafness
6%
Retina Maculopathy
6%
Myasthenia gravis
6%
Interstitial Lung Disease
6%
Anti-Inflammation
6%
Gastrointestinal Disease
6%
Erethism
6%
Glucose 6 Phosphate Dehydrogenase Deficiency
6%
Neurologic Disease
6%
Chronic Lung Disease
6%
Bronchiectasis
6%
Hematologic Disease
6%
Combination Therapy
6%
Hypoglycemia
6%
Liver Disease
6%
Retinopathy
6%
Psoriasis
6%
4 Aminoquinoline Derivative
6%
Superinfection
6%
Digoxin
6%
